Back to Results
First PageMeta Content
Pharmacy / Pharmaceutics / Cephalon / Pharmaceutical industry / Tolerx


Lycera Expands Leadership Team, Names H. Jeffrey Wilkins, M.D., as Chief Medical Officer - Dr. Wilkins to lead advancement of Lycera’s clinical programs, including first clinical trial anticipated to begin in 2Q 2015 N
Add to Reading List

Document Date: 2015-03-11 10:40:38


Open Document

File Size: 203,27 KB

Share Result on Facebook

City

ANN ARBOR / NEW YORK / /

Company

InterWest Partners / Actelion Pharmaceuticals / Clarus Ventures / Lycera Corp. / Clinical Development / GlaxoSmithKline / Merck / ARCH Venture Partners / Ceptaris Therapeutics Inc. / Cephalon Inc. / NeXeption LLC / Ception Therapeutics / TriValley Primary Care / EDF Ventures / /

Event

Funding / Employment Change / FDA Phase / M&A / /

Facility

Temple University / Bucknell University / /

IndustryTerm

biopharmaceutical company developing breakthrough medicines / treatment of cutaneous T-cell lymphoma / biopharmaceutical management / biopharmaceutical company advancing novel treatments / therapies for autoimmune disorders / immuno-oncology applications / large multi-center primary / pharmaceutical industry joining / /

MedicalCondition

inflammatory bowel disease / autoimmune diseases / autoimmune disorders / cutaneous T-cell lymphoma / cancer / autoimmune disease / eosinophilic asthma / Inflammation / /

MedicalTreatment

small molecule therapies / /

Organization

Bucknell University / GSK / Temple University / /

Person

H. Jeffrey Wilkins / Paul Sekhri / /

Position

Vice President / Vice President of Discovery Medicine / Co-Founder and Chief Executive Officer / Director Group / Vice President / Worldwide Clinical Research / Inflammation/Oncology / Chief Medical Officer / President and CEO / Medical Officer / Chief Medical Officer and Head of Medical Affairs / Chief / /

Product

VESIcare / Levitra / VALCHLOR / VALCHLOR® gel / /

ProvinceOrState

Michigan / Pennsylvania / /

Technology

cell signaling / Drug Discovery / drug development / /

URL

www.lycera.com / /

SocialTag